Citadel Advisors
GUTS icon

Citadel Advisors’s Fractyl Health GUTS Stock Holding History

Citadel Advisors’s Portfolio GUTS Stock Details GUTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-48,196
Closed -$22.1K – 15036
2026
Q1 		$22.1K Sell
48,196
-180,789
-79% -$167K ﹤0.01% 12650
2025
Q4 		$504K Sell
228,985
-1,553,371
-87% -$2.5M ﹤0.01% 9000
2025
Q3 		$2.83M Buy
+1,782,356
New +$2.31M ﹤0.01% 5404
2025
Q2 		– Sell
-100,345
Closed -$119K – 15473
2025
Q1 		$119K Sell
100,345
-631,664
-86% -$1.01M ﹤0.01% 11211
2024
Q4 		$1.51M Sell
732,009
-90,821
-11% -$211K ﹤0.01% 6211
2024
Q3 		$2.08M Buy
822,830
+32,573
+4% +$106K ﹤0.01% 5455
2024
Q2 		$3.37M Sell
790,257
-913,579
-54% -$5.88M ﹤0.01% 4374
2024
Q1 		$12.6M Buy
+1,703,836
New +$14.3M ﹤0.01% 2623

Other funds holding GUTS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors's GUTS Position: Q2 2026 in Review

Citadel Advisors sold out of Fractyl Health (GUTS) in Q2 2026, closing a stake of 48,196 shares — an estimated $22.1K sold.

Citadel Advisors first reported a position in GUTS in Q1 2024 and held it in 8 quarters. The position peaked at $12.6M in Q1 2024. 77 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

  • Citadel Advisors reported no remaining Fractyl Health position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 48,196 Fractyl Health shares in Q2 2026, an estimated $22.1K.
  • Citadel Advisors first reported a position in Fractyl Health in Q1 2024 and held it in 8 quarters.
  • Citadel Advisors's Fractyl Health position peaked at $12.6M in Q1 2024.
  • 77 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.